Economic considerations of macular edema therapies

Ophthalmology

Volumn 118, Issue 9, 2011, Pages 1827-1833

  Smiddy, William E ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; DEXAMETHASONE; PEGAPTANIB; RANIBIZUMAB; TRIAMCINOLONE ACETONIDE;

ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CLINICAL TRIAL (TOPIC); COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DIABETIC MACULAR EDEMA; DISEASE ASSOCIATION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; LOW LEVEL LASER THERAPY; META ANALYSIS; MODEL; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

AGED; ANGIOGENESIS INHIBITORS; COST-BENEFIT ANALYSIS; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; LASER COAGULATION; MACULAR EDEMA; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL ACUITY;

EID: 80052445162     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.12.034     Document Type: Article

References (53)

1. Early Treatment Diabetic Retinopathy Study Research Group Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1 Arch Ophthalmol 103 1985 1796 1806
2. Branch Vein Occlusion Study Group Argon laser photocoagulation for macular edema in branch retinal vein occlusion Am J Ophthalmol 98 1984 271 282
3. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion: the Central Vein Occlusion Study Group M report Ophthalmology 102 1995 1425 1433
4. J.M. Lin, Y.T. Chiu, P.R. Hung, and Y.Y. Tsai Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-Tenon triamcinolone acetonide Retina 27 2007 180 189
5. S. Nakano, T. Yamamoto, and E. Kirii Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema Graefes Arch Clin Exp Ophthalmol 248 2010 805 810
6. D.M. Brown, P.K. Kaiser, M. Michels ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444 (Pubitemid 44511558)
7. P.J. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431 (Pubitemid 44511557)
8. W.G. Roberts, and G.E. Palade Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor J Cell Sci 108 1995 2369 2379
9. D.A. Antonetti, J.A. Barber, and L.A. Hollinger Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1: a potential mechanism for vascular permeability in diabetic retinopathy and tumors J Biol Chem 274 1999 23463 23467
10. Q.D. Nguyen, S. Tatlipinar, and S.M. Shah Vascular endothelial growth factor is a critical stimulus for diabetic macular edema Am J Ophthalmol 142 2006 961 969
11. P.A. Campochiaro, G. Hafiz, and S.M. Shah Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator Mol Ther 16 2008 791 799 (Pubitemid 351426182)
12. J.B. Jonas, and A. Sofker Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema Am J Ophthalmol 132 2001 425 427 (Pubitemid 32768624)
13. C.K. Chan, S. Mohamed, and V.Y. Lee Intravitreal dexamethasone for diabetic macular edema: a pilot study Ophthalmic Surg Lasers Imaging 41 2010 26 30
14. J.B. Jonas, I. Akkoyun, and B. Kamppeter Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide Eye (Lond) 19 2005 65 71 (Pubitemid 40192642)
15. J.B. Jonas, I. Kreissig, and R.F. Degenring Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 240 2002 782 783 (Pubitemid 36097108)
16. B.D. Kuppermann, M.S. Blumenkranz, J.A. Haller Dexamethasone DDS Phase II Study Group Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema Arch Ophthalmol 125 2007 309 317 (Pubitemid 46425557)
17. P.A. Campochiaro, G. Hafiz, S.M. Shah Famous Study Group Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert Ophthalmology 117 2010 1393 1399
18. Macugen Diabetic Retinopathy Study Group A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema Ophthalmology 112 2005 1747 1757
19. D.S. Lam, T.Y. Lai, and V.Y. Lee Efficacy of 1.25 mg versus 2.5 mg intravitreal bevacizumab for diabetic macular edema: six-month results of a randomized controlled trial Retina 29 2009 292 299
20. D.W. Chun, J.S. Heier, and T.M. Topping A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema Ophthalmology 113 2006 1706 1712 (Pubitemid 44442451)
21. L. Wu, F. Arevalo, and M.H. Berrocal Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months Retina 29 2009 1396 1403
22. S.G. Priglinger, A.H. Wolf, and T.C. Kreutzer Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial Retina 27 2007 1004 1012 (Pubitemid 350303999)
23. D. Iturralde, R.F. Spaide, and C.B. Meyerle Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study Retina 26 2006 279 284 (Pubitemid 44318180)
24. A. Rouvas, P. Petrou, and I. Vergados Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study Graefes Arch Clin Exp Ophthalmol 247 2009 1609 1616
25. H.L. Lewis, G.W. Abrams, M.S. Blumenkranz, and R.V. Campo Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction Ophthalmology 99 1992 753 759
26. E.M. Opremcak, and R.A. Bruce Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases Retina 19 1999 1 5 (Pubitemid 30387533)
27. E.M. Opremcak, R.A. Bruce, and M.D. Lomeo Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases Retina 21 2001 408 415 (Pubitemid 32971349)
28. W.E. Smiddy The relative cost of a line of vision in age-related macular degeneration Ophthalmology 114 2007 847 854 (Pubitemid 46635838)
29. W.E. Smiddy Economic implications of current age-related macular degeneration treatments Ophthalmology 116 2009 481 487
30. Diabetic Retinopathy Clinical Research Network (DRCR.net) Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema Arch Ophthalmol 127 2009 245 251
31. SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 6 Arch Ophthalmol 127 2009 1115 1128
32. SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5 Arch Ophthalmol 127 2009 1101 1114
33. J.A. Haller, B.D. Kuppermann, M.S. Blumenkranz Dexamethasone DDS Phase II Study Group Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema Arch Ophthalmol 128 2010 289 296
34. J.A. Haller, F. Bandello, R. Belfast Jr OZURDEX GENEVA Study Group Randomized sham-controlled trial of dexamethasone implant in patients with macular edema due to retinal vein occlusion Ophthalmology 117 2010 1134 1146
35. J.J. Wroblewski, J.A. Wells III, and C.R. Gonzales Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion Am J Ophthalmol 149 2010 147 154
36. J.J. Wroblewski, J.A. Wells III, A.P. Adamis Pegaptanib in Central Retinal Vein Occlusion Study Group Pegaptanib sodium for macular edema secondary to central retinal vein occlusion Arch Ophthalmol 127 2009 374 380
37. J.F. Arevalo, J.G. Sanchez, J. Fromow-Guerra Pan-American Collaborative Retina Study Group (PACORES) Comparison of two does of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up Graefes Arch Clin Exp Ophthalmol 247 2009 735 743
38. L. Wu, J.F. Arevalo, and M.H. Berrocal Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months Retina 30 2010 1002 1011
39. M.J. Elman, L.P. Aiello, R.W. Beck Diabetic Retinopathy Research Network Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Ophthalmology 117 2010 1064 1077
40. P.A. Campochiaro, J.S. Heier, L. Feiner BRAVO Investigators Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1102 1112
41. D.M. Brown, P.A. Campochiaro, R.P. Singh CRUISE Investigators Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1124 1133
42. Diabetic Retinopathy Clinical Research Network Writing Committee on behalf of the DRCR.net Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction Ophthalmology 117 2010 1087 1093
43. Medicare Program: Changes to the Hospital Outpatient Prospective Payment System and CY 2010 Payment Rates; Changes to the Ambulatory Surgical Center Payment System and CY 2010 Payment Rates Federal Register 2009;74:60854, 60817, 6089560901 http://edocket.access.gpo.gov/2009/pdf/E9-26499.pdf Accessed December 11, 2010
44. United States Social Security Administration Online Actuarial Publications. Period Life Table, 2006 http://www.ssa.gov/oact/STATS/table4c6. html Accessed August 25, 2010
45. M.M. Brown, G.C. Brown, S. Sharma, and J. Landy Health care economic analyses and value-based medicine Surv Ophthalmol 48 2003 204 223 (Pubitemid 36398575)
46. M. Michaelides, A. Kaines, and R.D. Hamilton A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT Study): 12-month data: report 2 Ophthalmology 117 2010 1078 1086
47. Q.D. Nguyen, S.M. Shah, J.S. Heier READ-2 Study Group Primary end point (six months) results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) study Ophthalmology 116 2009 2175 2181
48. S.L. Rogers, R.L. McIntosh, and L. Lim Natural history of branch retinal vein occlusion: an evidence-based systematic review Ophthalmology 117 2010 1094 1101
49. Central Vein Occlusion Study Group Natural history and clinical management of central retinal vein occlusion Arch Ophthalmol 115 1997 486 491
50. R.L. McIntosh, S.L. Rogers, and L. Lim Natural history of central retinal vein occlusion: an evidence-based systematic review Ophthalmology 117 2010 1113 1123
51. R.M. Dafer, M. Schneck, T.R. Friberg, and W.M. Jay Intravitreal ranibizumab and bevacizumab: a review of risk Semin Ophthalmol 22 2007 201 204 (Pubitemid 47346972)
52. J.C. Javitt, J.K. Canner, and R.G. Frank Detecting and treating retinopathy in patients with type I diabetes mellitus: a health policy model Ophthalmology 97 1990 483 495 (Pubitemid 20108455)
53. T.E. Clemons, E.Y. Chew, S.B. Bressler, W. McBee AREDS Research Group National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS report no. 10 Arch Ophthalmol 121 2003 211 217 (Pubitemid 36184034)